Cold Laser Therapy Market to witness significant growth by older populations, looking for complementary and alternative medicine, and implementing non-invasive treatments

Market Research Future (MRFR) has published a latest research report on the “Global Cold Laser Therapy Market” that contains information from 2018 to 2032.

Market Highlights

The global Cold Laser Therapy market is accounted to register a CAGR of 4.50% during the forecast period and is estimated to reach USD 16.8 billion by 2032.

The continued development of Cold Laser Therapy technology is revolutionizing treatment efficacy. Medical devices are becoming more sophisticated, precise, and adaptive as a result of these innovative developments, which enables them to effectively treat a greater variety of medical conditions. The advancement of laser systems allows for optimal and targeted therapeutic results, satisfying a variety of medical needs. Technological developments have improved the therapeutic potential of cold laser therapy, offering patients and practitioners a more advanced and comprehensive approach to treating conditions ranging from musculoskeletal issues to dermatological issues. As a result, the therapy is gaining traction in several medical specialties.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Cold Laser Therapy Market Research Report

Segment Analysis

The global Cold Laser Therapy market has been segmented based on Product, Technology, and Applications

Based on Product, the global Cold Laser Therapy market has been segmented into Cat, Pulse Laser Devices, and Combination Laser Devices. The Combination Laser Devices segment was expected to hold the largest market share in 2022. Constant laser energy helps reduce swelling and inflammation by stimulating the lymphatic system and blood flow. By preventing the brain from sending pain signals to the treated area, pulsed laser light also has an analgesic effect there. Furthermore, scanning continuous laser devices to provide tissue exposure time that produces a tissue effect similar to pulsed lasers can increase the efficacy of therapy.

Based on Technology, the global Cold Laser Therapy market has been segmented into Multiple Wavelength Cold Laser Therapy Devices and single Wavelength Cold Laser Therapy Devices. The Single Wavelength Cold Laser Therapy Devices segment was anticipated to hold the major market share in 2022. Stimulation of tissues treated with single-wavelength cold laser therapy leads to increased cellular energy and ATP production, which supports various biological responses, including pain management.

Based on Applications, the global Cold Laser Therapy market has been segmented into Pain Management, Arthritis, Wound Healing, Nerve Regeneration, Dermatology, and Others. The Online segment was anticipated to hold the major market share in 2022. Since cold laser therapy doesn't involve surgery, it is a non-invasive procedure. The several medical, dermatological, and aesthetic conditions can be treated with laser therapy.

Key Players:

MRFR recognizes the following companies as the key players in the global Cold Laser Therapy market— Apira Science Inc., B-Cure laser Australia, Erchonia Corporation, Theralase Inc., DJO Global Inc., BTL Corporate, BioLight Technologies LLC, THOR Photomedicine Ltd, PhotoMedex, Lexington International LLC, MICROLIGHT Corporation, Apollo (Pivotal Health Care LLC), and Irradia.

Regional Analysis

The global Cold Laser Therapy market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Cold Laser Therapy market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Cold Laser Therapy market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Cold Laser Therapy market comprises of Middle East, Africa, and Latin America.  

The largest market share for Cold Laser Therapy was maintained by the North American regional sector. The two main causes of the region's notable growth are the rising prevalence of chronic pain associated with a variety of diseases among North Americans and the extensive use of cold lasers in medical facilities for pain relief and sports injuries.

Moreover, the Europe market has been persistently growing over the forecast period. Cold laser therapy is quickly spreading throughout Europe as a result of its non-invasiveness, proven effectiveness in treating a variety of medical conditions, and patients' growing preference for non-pharmacological, alternative treatment options.

Additionally, the cold laser therapy market in Asia-Pacific is anticipated to grow at the fastest compound annual growth rate (CAGR). Cold laser therapy is rapidly growing in the Asia Pacific region because of its non-invasive nature, capacity to treat a wide range of conditions, and growing demand for complementary and alternative healthcare options.

Furthermore, the rest of the world's Cold Laser Therapy market is divided into the Middle East, Africa, and Latin America. This growth is attributed to the rising prevalence of chronic diseases and technological advancement.

Key Findings of the Study

• The global Cold Laser Therapy market is expected to reach USD 0.1857 billion by 2032, at a CAGR of 4.50% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to rapid urbanization and a growing middle-class population in countries like China and India leading to the rising prevalence of chronic diseases and technological advancement.


• Based on Product, the Combination Laser Devices segment was attributed to holding the largest market in 2022, with an approximate market share of 55%.


• Apira Science Inc., B-Cure laser Australia, Erchonia Corporation, Theralase Inc., DJO Global Inc., BTL Corporate, BioLight Technologies LLC, THOR Photomedicine Ltd, PhotoMedex, Lexington International LLC, MICROLIGHT Corporation, Apollo (Pivotal Health Care LLC), and Irradia.